Given their potential to treat rare, inherited diseases, as
well as those previously deemed incurable, the field of gene therapy has gained
significant traction in the last few years
Roots Analysis is pleased to
announce the publication of its recent study, titled, “Gene Therapy Market (4th Edition), 2020-2030”.
The report features an extensive study of the current
market landscape of gene therapies, primarily focusing on gene
augmentation-based therapies, oncolytic viral therapies, immunotherapies and
gene editing therapies. The study also features an elaborate discussion on the
future potential of this evolving market. In addition to other elements, the
study includes:
§ A
detailed review of the overall market landscape of gene therapies and gene
editing therapies, including information on phase of development of pipeline
candidates, key therapeutic areas, target disease indication(s), type of vector
used, type of gene, type of modification, type of gene therapy, route of
administration and special drug designation(s) awarded (if any).
§ A
detailed review of the players engaged in the development of gene therapies.
§ An
elaborate discussion on the various types of viral and non-viral vectors.
§ A
discussion on the regulatory landscape related to gene therapies across various
geographies, namely North America, Europe and Asia-Pacific.
§ Detailed
profiles of marketed and late stage (phase II/III and above) gene therapies.
§ An
elaborate discussion on the various commercialization strategies that can be
adopted by drug developers across different stages of therapy development.
§ A
review of the various emerging technologies and therapy development platforms
that are being used to design and manufacture gene therapies.
§ An
in-depth analysis of various patents that have been filed / granted related to
gene therapies and gene editing therapies, since 2016.
§ A
detailed analysis of the various mergers and acquisitions that have taken place
within this domain, during the period 2015-2020.
§ An
analysis of the investments made at various stages of development in companies
that are focused in this area, between 2015-2020.
§ A
detailed geographical clinical trial analysis of completed, ongoing and planned
studies of numerous gene therapies.
§ An
analysis of the various factors that are likely to influence the pricing of
gene therapies.
§ An
analysis of the big biopharma players engaged in this domain.
§ An
informed estimate of the annual demand for gene therapies.
§ A
case study on the prevalent and emerging trends related to vector manufacturing.
§ A
discussion on the various operating models adopted by gene therapy developers
for supply chain management.
§ A detailed market forecast, featuring analysis of the
current and projected future opportunity across key market segments (listed
below)
To request for sample
– https://www.rootsanalysis.com/reports/view_document/gene-therapies-market/268.html
- Therapeutic Approach
§ Gene
augmentation
§ Oncolytic
therapy
§ Immunotherapy
§ Others
- Type of gene therapy
§ Ex vivo
§ In vivo
- Type of vector used
§ Adeno
associated virus
§ Adenovirus
§ Herpes
simplex virus
§ Lentivirus
§ Plasmid
DNA
§ Retrovirus
§ Others
- Key therapeutic areas
§ Autoimmune disorders
§ Cardiovascular
diseases
§ Dermatological
disorders
§ Genetic disorders
§ Hematological
disorders
§ Metabolic disorders
§ Muscle-related
diseases
§ Oncological disorders
§ Ophthalmic diseases
§ Others
- Route of administration
§ Intraarticular
§ Intracerebellar
§ Intradermal
§ Intramuscular
§ Intratumoral
§ Intravenous
§ Intravesical
§ Intravitreal
§ Subretinal
§ Others
- Key geographical regions
§ North
America
§ Europe
§ Asia-Pacific
Key
companies covered in the report
§ Abeona Therapeutics
§ Advantagene
§ Biogen
§ bluebird bio
§ Castle Creek Biosciences
§ CG Oncology
§ FerGene
§ Freeline Therapeutics
§ Gradalis
§ Helixmith
§ Inovio Pharmaceuticals
§ Kolon TissueGene
§ Krystal Biotech
§ Lysogene
§ Neurophth Therapeutics
§ OncoSec Immunotherapies
§ Orchard Therapeutics
§ Pfizer
§ Sangamo Therapeutics
§ Spark Therapeutics
§ uniQure Biopharma
§ VBL Therapeutics
For
more information, please click on the following link:
https://www.rootsanalysis.com/reports/view_document/gene-therapies-market/268.html
Other Recent Offerings
1. Viral
Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market (4th
Edition), 2021-2030
2. Global
T-Cell (CAR-T, TCR, and TIL) Therapies Market (5th Edition), 2020-2030
3. Oncolytic
Virus Therapy Market: Pipeline Review, Developer Landscape and Competitive
Insights, 2020-2030
About Roots Analysis
Roots Analysis is one of the fastest
growing market research companies, sharing fresh and independent perspectives
in the bio-pharmaceutical industry. The in-depth research, analysis and
insights are driven by an experienced leadership team which has gained many
years of significant experience in this sector. If you’d like help with your
growing business needs, get in touch at info@rootsanalysis.com
Contact Information
Roots Analysis Private
Limited
Gaurav Chaudhary
+1 (415) 800 3415
Facebook - https://www.facebook.com/RootsAnalysis
LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/
Twitter - https://twitter.com/RootsAnalysis